Optimizing Treatment with Cabergoline 0.25 mg for Prolactinomas
IntroductionCabergoline 0.25 mg is a dopamine agonist with extensive applications in the management of hyperprolactinemia (high prolactin levels) and prolactinomas (pituitary tumors secreting excess prolactin). Cabergoline 0.25 mg, with its long half-life and...
0 Commenti 0 condivisioni 2K Views 0 Anteprima
Pubblicità